SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating CTI BioPharma Corp. Buyout

Loading...
Loading...

Wilmington, Delaware--(Newsfile Corp. - May 11, 2023) - Rigrodsky Law, P.A. is investigating CTI BioPharma Corp. ("CTI") CTIC regarding possible breaches of fiduciary duties and other violations of law related to CTI's agreement to be acquired by Swedish Orphan Biovitrum AB. Under the terms of the agreement, CTI shareholders will receive $9.10 per share in cash.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-cti-biopharma-corp.

To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:
Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Call or Text: (302) 295-5310
Email: info@rl-legal.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/165762

Posted In: Press Releases
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...